Cambridge, UK - 20th December 2018
Nuformix Announces Unaudited Half Year Results for the Period Ending 30 September 2018
Nuformix (LSE: NFX), the pharmaceutical development company using cocrystal…
Cambridge, UK - 20th December 2018
Nuformix (LSE: NFX), the pharmaceutical development company using cocrystal…
Cambridge, UK - 3rd December 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 27th November 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 28th September 2018
The Company was notified on 28 September 2018 that Kirk…
Cambridge, UK - 28th September 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 19th September 2018
The Annual General Meeting of Nuformix plc was held on…
Cambridge, UK - 14th September 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 28th August 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 16th August 2018
The Company announces that the following documents were posted to…
Cambridge, UK - 15th August 2018
Nuformix PLC – Annual General Meeting – Proxy Form…
Cambridge, UK - 26th July 2018
The Board of Nuformix plc, (LSE:NFX) is pleased to announce…
Cambridge, UK - 4th July 2018
Cambridge, UK - 2nd July 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 26th June 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 11th May 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 24th April 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 2nd March 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 27th February 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 31st January 2018
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 15th December 2017
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 14th December 2017
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 6th December 2017
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 1st December 2017
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 19th October 2017
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 19th October 2017
Nuformix, the pharmaceutical development company using cocrystal technology to unlock…
Cambridge, UK - 18th October 2017
Since shares commenced their first days trading under…
Cambridge, UK - 17th October 2017
The news of the completion of Nuformix’s acquisition…
Cambridge, UK - 16th October 2017
Having worked on the original IPO of Levrett,…
Cambridge, UK - 16th October 2017
Nuformix CEO, Dan Gooding, provides a first summary…
Cambridge, UK - 16th October 2017
The news of the completion of Nuformix’s acquisition…
Cambridge, UK - 16th October 2017
As Nuformix shares commence their first days…
Cambridge, UK - 16th October 2017
The news of the completion of Nuformix’s acquisition…
Cambridge, UK - 16th October 2017
Following a Reverse Takeover on the London Stock Exchange’s market…
Cambridge, UK - 16th October 2017
Following a Reverse Takeover on the London Stock Exchange’s market…
Cambridge, UK - 16th October 2017
Corporate Introduction October 2017 – Click here to download…
Cambridge, UK - 13th October 2017
Levrett, a Company formed to acquire a target company with…
Cambridge, UK - 13th October 2017
Levrett, a Company formed to acquire a target company with…
Cambridge, UK - 13th October 2017
Levrett, a Company formed to acquire a target company with…
Cambridge, UK - 13th October 2017
Levrett plc announces that today the name of the Company…
Cambridge, UK - 13th October 2017
Levrett, a Company formed to acquire a target company with…
Cambridge, UK - 22nd September 2017
Cambridge, UK - 15th September 2017
Levrett plc, a Company formed to acquire a target company…
Cambridge, UK - 15th September 2017
Nuformix is delighted to announce that Levrett plc, a Company…
Cambridge, UK - 2nd May 2017
Nuformix has entered into an agreement with Fibrofind to conduct…
Cambridge, UK - 19th January 2017
Nuformix is pleased to announce it has today received the…
Cambridge, UK - 23rd December 2016
Levrett, a Company formed to acquire a target company with…
Cambridge, UK - 6th December 2016
Nuformix announces today that the US PTO has granted Nuformix’s…
Cambridge, UK - 30th November 2016
Following on from Nuformix’s existing cocrystal discovery and development pact…
Cambridge, UK - 23rd November 2016
Nuformix is pleased to announce the grant of its NXP001…
Cambridge, UK - 21st October 2016
Following completion of the first stage of its collaboration with…
Cambridge, UK - 4th October 2016
Nuformix will attend CPhI in Barcelona over 5 th –…
Cambridge, UK - 21st September 2016
Levrett announces that the Board has approved a change in…
Cambridge, UK - 16th September 2016
The Directors of Levrett are pleased to inform shareholders that…
Cambridge, UK - 15th September 2016
Following completion of the Innovate UK funded collaboration between Nuformix…
Cambridge, UK - 1st September 2016
In partnership with Newsummit Biopharma, a Nuformix strategic development partner,…
Cambridge, UK - 9th August 2016
Nuformix has received official notification from the Japanese PO of…
Cambridge, UK - 29th March 2016
Levrett is pleased to announce its interim results for the…
Cambridge, UK - 24th February 2016
Levrett is pleased to announce that it has appointed Whitman…
Cambridge, UK - 11th February 2016
Following the commencement of Nuformix’s partnership with Magnus Life Science,…
Cambridge, UK - 17th December 2015
Levrett is pleased to announce that its entire issued ordinary…